These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 6345041

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E, Ulrich M, Aranzazu N, Santaella C, Gallinoto M, Centeno M, Rodriguez V, Convit J.
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [Abstract] [Full Text] [Related]

  • 44. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy.
    Spierings E, de Boer T, Wieles B, Adams LB, Marani E, Ottenhoff TH.
    J Immunol; 2001 May 15; 166(10):5883-8. PubMed ID: 11342602
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Etiological factors in delayed-type hypersensitivity reactions in leprosy.
    Klenerman P.
    Int J Lepr Other Mycobact Dis; 1987 Dec 15; 55(4):702-12. PubMed ID: 3123582
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Host parasite response in nerve in leprosy.
    Turk JL.
    Indian J Lepr; 1996 Dec 15; 68(1):113-7. PubMed ID: 8727123
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 15; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Immunochemical characterization of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immunoperoxidase technique (SGIP) using patients' sera.
    Klatser PR, van Rens MM, Eggelte TA.
    Clin Exp Immunol; 1984 Jun 15; 56(3):537-44. PubMed ID: 6378452
    [Abstract] [Full Text] [Related]

  • 60. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
    Jeevan A, Bapat CV.
    Indian J Lepr; 1984 Jun 15; 56(4):754-63. PubMed ID: 6398339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.